BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28900036)

  • 1. Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.
    Li Z; Liu J; Li J; Kong Y; Sandusky G; Rao X; Liu Y; Wan J; Liu X
    J Biol Chem; 2017 Oct; 292(42):17461-17472. PubMed ID: 28900036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plk1 phosphorylation of Numb leads to impaired DNA damage response.
    Shao C; Chien SJ; Farah E; Li Z; Ahmad N; Liu X
    Oncogene; 2018 Feb; 37(6):810-820. PubMed ID: 29059161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers.
    Takahashi T; Sano B; Nagata T; Kato H; Sugiyama Y; Kunieda K; Kimura M; Okano Y; Saji S
    Cancer Sci; 2003 Feb; 94(2):148-52. PubMed ID: 12708489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of polo-like kinase 1 in human gastric cancer.
    Weichert W; Ullrich A; Schmidt M; Gekeler V; Noske A; Niesporek S; Buckendahl AC; Dietel M; Denkert C
    Cancer Sci; 2006 Apr; 97(4):271-6. PubMed ID: 16630118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive DNA damage signaling for low‑dose ionizing radiation.
    Park JI; Jung SY; Song KH; Lee DH; Ahn J; Hwang SG; Jung IS; Lim DS; Song JY
    Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38695243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHK2 kinase in the DNA damage response and beyond.
    Zannini L; Delia D; Buscemi G
    J Mol Cell Biol; 2014 Dec; 6(6):442-57. PubMed ID: 25404613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chk2 sustains PLK1 activity in mitosis to ensure proper chromosome segregation.
    Black EM; Ramírez Parrado CA; Trier I; Li W; Joo YK; Pichurin J; Liu Y; Kabeche L
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
    Chandler BC; Moubadder L; Ritter CL; Liu M; Cameron M; Wilder-Romans K; Zhang A; Pesch AM; Michmerhuizen AR; Hirsh N; Androsiglio M; Ward T; Olsen E; Niknafs YS; Merajver S; Thomas DG; Brown PH; Lawrence TS; Nyati S; Pierce LJ; Chinnaiyan A; Speers C
    J Clin Invest; 2020 Feb; 130(2):958-973. PubMed ID: 31961339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1.
    Birger Y; Catez F; Furusawa T; Lim JH; Prymakowska-Bosak M; West KL; Postnikov YV; Haines DC; Bustin M
    Cancer Res; 2005 Aug; 65(15):6711-8. PubMed ID: 16061652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination.
    Feng W; Jasin M
    Nat Commun; 2017 Sep; 8(1):525. PubMed ID: 28904335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy.
    Wang B; Huang X; Liang H; Yang H; Guo Z; Ai M; Zhang J; Khan M; Tian Y; Sun Q; Mao Z; Zheng R; Yuan Y
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1234-1247. PubMed ID: 33621661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark side of PLK1: Implications for cancer and genomic instability.
    Gheghiani L; Fu Z
    Oncotarget; 2023 Jun; 14():657-659. PubMed ID: 37367493
    [No Abstract]   [Full Text] [Related]  

  • 13. Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway.
    Wang R; Hou Y; Geng G; Zhu X; Wang Z; Cai W; Ye J; Zhao S; Mi Y; Jiang J
    Am J Cancer Res; 2023; 13(2):623-637. PubMed ID: 36895968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anaphase-Promoting Complex/Cyclosome Is a Cellular Ageing Regulator.
    Hu X; Jin X; Cao X; Liu B
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinase PLK1 promotes the development of
    Kong Y; Allison DB; Zhang Q; He D; Li Y; Mao F; Li C; Li Z; Zhang Y; Wang J; Wang C; Brainson CF; Liu X
    Sci Signal; 2022 Oct; 15(754):eabj4009. PubMed ID: 36194647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis.
    Gheghiani L; Wang L; Zhang Y; Moore XTR; Zhang J; Smith SC; Tian Y; Wang L; Turner K; Jackson-Cook CK; Mukhopadhyay ND; Fu Z
    Cancer Res; 2021 Mar; 81(5):1293-1307. PubMed ID: 33376114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CINs of Polo-Like Kinase 1 in Cancer.
    Cunningham CE; MacAuley MJ; Vizeacoumar FS; Abuhussein O; Freywald A; Vizeacoumar FJ
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.
    VanGenderen C; Harkness TAA; Arnason TG
    Aging (Albany NY); 2020 Aug; 12(15):15818-15855. PubMed ID: 32805721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chk2-dependent phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) regulates centrosome maturation.
    Nai S; Shi Y; Ru H; Ding Y; Geng Q; Li Z; Dong MQ; Xu X; Li J
    Cell Cycle; 2019 Oct; 18(20):2651-2659. PubMed ID: 31416392
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.